Multiple Sclerosis Clinical Trial
Official title:
Cognitive Evolution in Tysabri Treated Multiple Sclerosis Patients - A Three Year Extension
This study is designed to demonstrate that Tysabri is effective in maintaining cognition in
MS patients after 5 or more years of continuous treatment.
During a second period of 36 months, the extension study will assess the evolution of
cognitive function in Tysabri treated MS patients using the Symbol Digit Modalities Test
(SDMT) and a CogState battery of tests.
Tysabri reduces the relapse frequency, slows progression and preserves cognitive function as
compared to placebo as per the AFFIRM trial. The benefit on relapse rate and progression
appears to be sustained in longer-term studies such as STRATA. In clinical practice however
despite a stable EDSS patients often complain of cognitive deterioration.
The investigators' preliminary results from the first pilot study have shown that cognition
in Tysabri treated MS patients for two or more years, as measured by the SDMT or Cogstate
battery is maintained, including the ability to learn. The investigators' final data will be
presented at the American Academy of Neurology (AAN) in 2015.
The Symbol Digit Modalities Test (SDMT) is a sensitive and validated test of cognition in MS.
CogState offers a standardized battery of cognitive tests frequently used in clinical
research in the fields of dementia and Parkinson's disease. The CogState battery of tests
consisting of the Detection test (processing speed), Identification test (attention), One
Back test (working memory), International Shopping List test (verbal learning) and the Groton
Maze Learning test (reasoning and problem solving) will further confirm and validate the
results of the SDMT in MS patients as well as examine other cognitive domains.
The Beck Depression Inventory-II [Beck 1996] is a validated and well recognized clinical
research tool for depression in the field of multiple sclerosis.
Together the above tests done prospectively can assess the evolution of cognitive function in
Tysabri treated MS patients over the longer term.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05528666 -
Risk Perception in Multiple Sclerosis
|
||
Completed |
NCT03608527 -
Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis
|
N/A | |
Recruiting |
NCT05532943 -
Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
|
Phase 1/Phase 2 | |
Completed |
NCT02486640 -
Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
|
||
Completed |
NCT01324232 -
Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT04546698 -
5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
|
||
Active, not recruiting |
NCT04380220 -
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
|
||
Completed |
NCT02835677 -
Integrating Caregiver Support Into MS Care
|
N/A | |
Completed |
NCT03686826 -
Feasibility and Reliability of Multimodal Evoked Potentials
|
||
Recruiting |
NCT05964829 -
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
|
N/A | |
Withdrawn |
NCT06021561 -
Orofacial Pain in Multiple Sclerosis
|
||
Completed |
NCT03653585 -
Cortical Lesions in Patients With Multiple Sclerosis
|
||
Recruiting |
NCT04798651 -
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
|
N/A | |
Active, not recruiting |
NCT05054140 -
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT05447143 -
Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis
|
N/A | |
Recruiting |
NCT06195644 -
Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients
|
Phase 1 | |
Completed |
NCT04147052 -
iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis
|
N/A | |
Completed |
NCT03594357 -
Cognitive Functions in Patients With Multiple Sclerosis
|
||
Completed |
NCT03591809 -
Combined Exercise Training in Patients With Multiple Sclerosis
|
N/A | |
Completed |
NCT02845635 -
MS Mosaic: A Longitudinal Research Study on Multiple Sclerosis
|